In contrast, a recent report indicated an oncogenic role of Xist in glioblastoma stem cells by evidence that Xist expression was elevated in glioma tissues and that Xist knockdown reduced cell proliferation, migration and invasion in glioblastoma stem cells [6]. Here, XIST is linked to central nervous system cancer.